Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk.
CONCLUSION: In real-world patients at high risk of bleeding, implantation of the polymer-free metallic stent coated with Biolimus-A9 (Biofreedom®; Biosensors Europe, Morges, Switzerland) followed by 1 -month DAPT showed encouraging results without any stent thrombosis.
PMID: 31965195 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
More News: Angioplasty | Aspirin | Bleeding | Cardiology | Clopidogrel | Coronary Angioplasty | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Percutaneous Coronary Intervention | Plavix | Statistics | Stroke | Study | Switzerland Health | Thrombosis